1. Home
  2. YMAB vs SRI Comparison

YMAB vs SRI Comparison

Compare YMAB & SRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • SRI
  • Stock Information
  • Founded
  • YMAB 2015
  • SRI 1965
  • Country
  • YMAB United States
  • SRI United States
  • Employees
  • YMAB N/A
  • SRI N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • SRI Auto Parts:O.E.M.
  • Sector
  • YMAB Health Care
  • SRI Consumer Discretionary
  • Exchange
  • YMAB Nasdaq
  • SRI Nasdaq
  • Market Cap
  • YMAB 192.4M
  • SRI 216.9M
  • IPO Year
  • YMAB 2018
  • SRI 1997
  • Fundamental
  • Price
  • YMAB $8.51
  • SRI $8.01
  • Analyst Decision
  • YMAB Buy
  • SRI Buy
  • Analyst Count
  • YMAB 11
  • SRI 1
  • Target Price
  • YMAB $15.02
  • SRI $16.00
  • AVG Volume (30 Days)
  • YMAB 1.3M
  • SRI 372.9K
  • Earning Date
  • YMAB 08-08-2025
  • SRI 08-06-2025
  • Dividend Yield
  • YMAB N/A
  • SRI N/A
  • EPS Growth
  • YMAB N/A
  • SRI N/A
  • EPS
  • YMAB N/A
  • SRI N/A
  • Revenue
  • YMAB $88,658,000.00
  • SRI $877,921,000.00
  • Revenue This Year
  • YMAB N/A
  • SRI N/A
  • Revenue Next Year
  • YMAB $15.23
  • SRI $10.18
  • P/E Ratio
  • YMAB N/A
  • SRI N/A
  • Revenue Growth
  • YMAB 4.92
  • SRI N/A
  • 52 Week Low
  • YMAB $3.55
  • SRI $3.54
  • 52 Week High
  • YMAB $16.11
  • SRI $15.46
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 81.64
  • SRI 57.36
  • Support Level
  • YMAB $4.16
  • SRI $6.91
  • Resistance Level
  • YMAB $8.54
  • SRI $8.52
  • Average True Range (ATR)
  • YMAB 0.24
  • SRI 0.66
  • MACD
  • YMAB 0.47
  • SRI -0.03
  • Stochastic Oscillator
  • YMAB 99.32
  • SRI 57.39

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

Share on Social Networks: